Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,819 | 208 | 55.6% |
| Consulting Fee | $9,260 | 2 | 37.2% |
| Travel and Lodging | $1,302 | 5 | 5.2% |
| Education | $439.89 | 13 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $8,585 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $4,186 | 30 | $0 (2024) |
| ABBVIE INC. | $3,473 | 37 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,224 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,183 | 30 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $873.45 | 8 | $0 (2022) |
| Genentech USA, Inc. | $603.62 | 15 | $0 (2022) |
| PFIZER INC. | $602.93 | 8 | $0 (2024) |
| Incyte Corporation | $495.02 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $480.12 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,817 | 17 | Janssen Biotech, Inc. ($336.83) |
| 2023 | $1,882 | 22 | AbbVie Inc. ($694.46) |
| 2022 | $1,856 | 17 | ABBVIE INC. ($566.76) |
| 2021 | $709.45 | 7 | AbbVie Inc. ($203.81) |
| 2020 | $359.97 | 3 | Janssen Biotech, Inc. ($125.00) |
| 2019 | $1,777 | 19 | AbbVie, Inc. ($578.81) |
| 2018 | $10,144 | 54 | GENZYME CORPORATION ($7,606) |
| 2017 | $6,328 | 90 | Janssen Biotech, Inc. ($3,513) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 2 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $112.98 | General |
| Category: Immunology | ||||||
| 07/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $132.14 | General |
| 06/22/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $126.90 | General |
| 05/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $8.88 | General |
| 04/22/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $115.18 | General |
| Category: Immunology | ||||||
| 04/10/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $55.25 | General |
| Category: Immunology | ||||||
| 04/04/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $97.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $8.88 | General |
| 02/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $8.88 | General |
| 02/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $8.88 | General |
| 02/20/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $66.04 | General |
| Category: Dermatology | ||||||
| 02/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $8.88 | General |
| 02/07/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $88.96 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2022 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $84.70 | General |
| Category: Immunology | ||||||
| 10/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $109.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $73.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $115.37 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2022 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $137.78 | General |
| Category: Immunology | ||||||
| 08/24/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $116.04 | General |
| Category: DERMATOLOGY | ||||||
| 08/23/2022 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $75.00 | General |
| Category: Inflammation & Immunology | ||||||
| 08/03/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/07/2022 | Galderma Laboratories, L.P. | TWYNEO (Drug) | Food and Beverage | In-kind items and services | $134.21 | General |
| Category: ACNE | ||||||
| 05/16/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $97.70 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,140 | 2,744 | $546,791 | $84,025 |
| 2022 | 14 | 1,052 | 2,527 | $471,680 | $77,854 |
| 2021 | 16 | 1,695 | 3,899 | $681,660 | $116,658 |
| 2020 | 19 | 1,752 | 4,317 | $629,096 | $98,659 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 298 | 522 | $169,986 | $32,888 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 129 | $59,016 | $9,417 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 109 | 109 | $44,258 | $8,474 | 19.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 105 | 119 | $66,757 | $7,695 | 11.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 85 | 98 | $60,993 | $7,312 | 12.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 119 | 148 | $55,056 | $5,713 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $21,019 | $3,351 | 15.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 23 | 23 | $16,035 | $2,190 | 13.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 31 | 49 | $13,720 | $1,884 | 13.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 159 | $12,500 | $1,610 | 12.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 28 | $8,888 | $1,114 | 12.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 70 | 1,133 | $5,089 | $871.44 | 17.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 72 | 178 | $6,408 | $828.12 | 12.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 13 | 14 | $7,066 | $678.49 | 9.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 305 | 504 | $163,061 | $32,053 | 19.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 105 | 105 | $42,090 | $8,692 | 20.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 106 | 115 | $64,477 | $8,045 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 82 | $37,408 | $7,491 | 20.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 115 | 148 | $53,973 | $6,042 | 11.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 60 | 71 | $43,742 | $5,592 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $11,387 | $2,278 | 20.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 29 | 44 | $12,464 | $1,754 | 14.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 77 | 321 | $11,400 | $1,599 | 14.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 63 | 138 | $10,685 | $1,422 | 13.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $7,741 | $800.27 | 10.3% |
About Dr. Douglas Robins, MD
Dr. Douglas Robins, MD is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265422729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Robins, MD has received a total of $24,873 in payments from pharmaceutical and medical device companies, with $1,817 received in 2024. These payments were reported across 229 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($13,819).
As a Medicare-enrolled provider, Robins has provided services to 5,639 Medicare beneficiaries, totaling 13,487 services with total Medicare billing of $377,196. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Jacksonville, FL
- Active Since 10/26/2005
- Last Updated 01/11/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1265422729
Products in Payments
- DUPIXENT (Drug) $7,891
- COSENTYX (Biological) $1,039
- Humira (Biological) $1,018
- RINVOQ (Biological) $973.45
- DUPIXENT (Biological) $906.48
- TREMFYA (Drug) $788.64
- SKYRIZI (Biological) $587.15
- Erivedge (Biological) $544.07
- OPZELURA (Drug) $495.02
- STELARA (Biological) $415.35
- Skyrizi (Biological) $397.43
- LIBTAYO (Biological) $359.21
- EPIDUO FORTE (Drug) $332.14
- Tremfya (Drug) $321.25
- DUPIXENT DUPILUMAB INJECTION (Biological) $316.76
- EUCRISA (Drug) $311.79
- TALTZ (Drug) $242.77
- Bimzelx (Biological) $241.77
- Enbrel (Biological) $227.33
- Sotyktu (Drug) $218.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
John Morello, M.d, M.D
Dermatology — Payments: $12,575